GSK plc (LON:GSK)
1,882p-1.90%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Hepatitis B cure trial success confirmed; October regulatory decision awaited; strong growth available cheaply.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operat…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- £77.8B
Recent dividends
- 14 May 202617.00p
- 19 Feb 202618.00p
- 13 Nov 202516.00p
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on GSK plc and 1,600+ UK and US stocks.
Start free